Publications by authors named "P Manoj"

Article Synopsis
  • - The study focuses on synthesizing a series of 4,6-diarylpyrimidin-2-amine derivatives that exhibit adjustable optical properties depending on the aryl groups attached to them, both in solid and solution states.
  • - The synthesized compounds showed significant variability in their optical characteristics, including absorption and emission rates, with quantum yields ranging from 8.11% to 71.00% in DMF and specific fluorescence lifetimes.
  • - The results suggest that these derivatives have potential applications in optoelectronics due to their unique dual-state emission properties and the ability to modify energy levels through different substituents.
View Article and Find Full Text PDF

This study aimed to investigate the potential protective effects of riociguat, a soluble guanylyl cyclase (sGC) stimulator, on kidney function and structure in rats with acute kidney injury (AKI) induced by the chemotherapeutic drug doxorubicin (DX). Rats were subjected to a single intraperitoneal injection of DX (13.5 mg/kg) on the 5th day, either alone or in combination with low-dose riociguat (3 mg/kg/day), or high-dose riociguat (10 mg/kg/day) for 8 consecutive days.

View Article and Find Full Text PDF

Objectives: The purpose of this study was to assess, in a tertiary care context, the significance of C-reactive protein (CRP) in salivary gland illness.

Methods: This prospective research included 100 consecutive individuals with symptoms indicative of illness of the salivary glands. Demographic information, clinical information, and presenting symptoms were noted.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with small-cell lung cancer (SCLC) usually have a hard time and don't get great results from current treatments.
  • A new study shows that blocking a protein called ATR can help destroy cancer cells and improve the immune system's response against tumors.
  • When ATR is blocked along with another treatment called PD-L1, it works better than PD-L1 alone, offering hope for new ways to help people with SCLC.
View Article and Find Full Text PDF